A citation-based method for searching scientific literature

Sourav Banerjee, Chenggong Ji, Joshua E Mayfield, Apollina Goel, Junyu Xiao, Jack E Dixon, Xing Guo. Proc Natl Acad Sci U S A 2018
Times Cited: 70







List of co-cited articles
551 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.
Xing Guo, Xiaorong Wang, Zhiping Wang, Sourav Banerjee, Jing Yang, Lan Huang, Jack E Dixon. Nat Cell Biol 2016
104
32

The Logic of the 26S Proteasome.
Galen Andrew Collins, Alfred L Goldberg. Cell 2017
426
17

The Essential Medicinal Chemistry of Curcumin.
Kathryn M Nelson, Jayme L Dahlin, Jonathan Bisson, James Graham, Guido F Pauli, Michael A Walters. J Med Chem 2017
745
15

Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
Sourav Banerjee, Tiantian Wei, Jue Wang, Jenna J Lee, Haydee L Gutierrez, Owen Chapman, Sandra E Wiley, Joshua E Mayfield, Vasudha Tandon, Edwin F Juarez,[...]. Proc Natl Acad Sci U S A 2019
24
45

cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins.
Sudarsanareddy Lokireddy, Nikolay Vadimovich Kukushkin, Alfred Lewis Goldberg. Proc Natl Acad Sci U S A 2015
149
12

Regulating protein breakdown through proteasome phosphorylation.
Jordan J S VerPlank, Alfred L Goldberg. Biochem J 2017
70
12

DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.
Naoe Taira, Rei Mimoto, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa, Yoshio Miki, Kiyotsugu Yoshida. J Clin Invest 2012
94
12

Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.
Natura Myeku, Catherine L Clelland, Sheina Emrani, Nikolay V Kukushkin, Wai Haung Yu, Alfred L Goldberg, Karen E Duff. Nat Med 2016
251
11

Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II.
Stevan N Djakovic, Lindsay A Schwarz, Barbara Barylko, George N DeMartino, Gentry N Patrick. J Biol Chem 2009
167
11

26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation.
Jordan J S VerPlank, Sudarsanareddy Lokireddy, Jinghui Zhao, Alfred L Goldberg. Proc Natl Acad Sci U S A 2019
59
13

DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
Rei Mimoto, Naoe Taira, Hiroyuki Takahashi, Tomoko Yamaguchi, Masataka Okabe, Ken Uchida, Yoshio Miki, Kiyotsugu Yoshida. Cancer Lett 2013
53
15


The protein kinase complement of the human genome.
G Manning, D B Whyte, R Martinez, T Hunter, S Sudarsanam. Science 2002
11

DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.
Naoe Taira, Keishi Nihira, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida. Mol Cell 2007
210
11

Reversible phosphorylation of the 26S proteasome.
Xing Guo, Xiuliang Huang, Mark J Chen. Protein Cell 2017
48
14

Structure and Function of the 26S Proteasome.
Jared A M Bard, Ellen A Goodall, Eric R Greene, Erik Jonsson, Ken C Dong, Andreas Martin. Annu Rev Biochem 2018
309
10

Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
Moisés Pérez, Carmen García-Limones, Inés Zapico, Anabel Marina, M Lienhard Schmitz, Eduardo Muñoz, Marco A Calzado. J Mol Cell Biol 2012
44
15

Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
Shiho Yokoyama-Mashima, Satomi Yogosawa, Yumi Kanegae, Shinichi Hirooka, Saishu Yoshida, Takashi Horiuchi, Toya Ohashi, Katsuhiko Yanaga, Masayuki Saruta, Tsunekazu Oikawa,[...]. Cancer Lett 2019
16
43

DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.
Noriko Yamaguchi, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka, Aikou Okamoto, Kiyotsugu Yoshida. Tumour Biol 2015
28
25

Regulation of proteasome assembly and activity in health and disease.
Adrien Rousseau, Anne Bertolotti. Nat Rev Mol Cell Biol 2018
185
8

Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6.
Fengxue Zhang, Yong Hu, Ping Huang, Clifford A Toleman, Andrew J Paterson, Jeffrey E Kudlow. J Biol Chem 2007
151
8


Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
Xiubing Zhang, Pan Xu, Wenkai Ni, Hui Fan, Jian Xu, Yongmei Chen, Wei Huang, Shumin Lu, Li Liang, Jinxia Liu,[...]. Pathol Res Pract 2016
24
25

Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.
R Mimoto, Y Imawari, S Hirooka, H Takeyama, K Yoshida. Oncogene 2017
22
27

Regulation of Glioma Cells Migration by DYRK2.
Yifen Shen, Li Zhang, Donglin Wang, Yifeng Bao, Chao Liu, Zhiwei Xu, Wei Huang, Chun Cheng. Neurochem Res 2017
10
60

Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Charles T Miller, Sanjeev Aggarwal, Theodore K Lin, Susan L Dagenais, Jorge I Contreras, Mark B Orringer, Thomas W Glover, David G Beer, Lin Lin. Cancer Res 2003
46
13

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Haiyan Yan, Kaishun Hu, Wenjing Wu, Yu Li, Huan Tian, Zhonghua Chu, H Phillip Koeffler, Dong Yin. PLoS One 2016
20
30


Structure and functions of the 20S and 26S proteasomes.
O Coux, K Tanaka, A L Goldberg. Annu Rev Biochem 1996
8

The selectivity of protein kinase inhibitors: a further update.
Jenny Bain, Lorna Plater, Matt Elliott, Natalia Shpiro, C James Hastie, Hilary McLauchlan, Iva Klevernic, J Simon C Arthur, Dario R Alessi, Philip Cohen. Biochem J 2007
8

Emerging roles of DYRK2 in cancer.
Vasudha Tandon, Laureano de la Vega, Sourav Banerjee. J Biol Chem 2021
16
37

Curcumin: from ancient medicine to current clinical trials.
H Hatcher, R Planalp, J Cho, F M Torti, S V Torti. Cell Mol Life Sci 2008
7

Protein kinase g positively regulates proteasome-mediated degradation of misfolded proteins.
Mark J Ranek, Erin J M Terpstra, Jie Li, David A Kass, Xuejun Wang. Circulation 2013
89
7

Phosphorylation of Rpt6 regulates synaptic strength in hippocampal neurons.
Stevan N Djakovic, Esther M Marquez-Lona, Sonya K Jakawich, Rebecca Wright, Carissa Chu, Michael A Sutton, Gentry N Patrick. J Neurosci 2012
89
7

Proteasome Activation by Small Molecules.
Yves Leestemaker, Annemieke de Jong, Katharina F Witting, Renske Penning, Karianne Schuurman, Boris Rodenko, Esther A Zaal, Bert van de Kooij, Stefan Laufer, Albert J R Heck,[...]. Cell Chem Biol 2017
85
7


Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.
Pamela A Lochhead, Gary Sibbet, Nick Morrice, Vaughn Cleghon. Cell 2005
214
7

Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.
Meera Soundararajan, Annette K Roos, Pavel Savitsky, Panagis Filippakopoulos, Arminja N Kettenbach, Jesper V Olsen, Scott A Gerber, Jeyanthy Eswaran, Stefan Knapp, Jonathan M Elkins. Structure 2013
97
7

Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.
Hae-Yun Jung, Xin Wang, Sohee Jun, Jae-Il Park. J Biol Chem 2013
45
11

Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.
Rei Mimoto, Naoe T Nihira, Shinichi Hirooka, Hiroshi Takeyama, Kiyotsugu Yoshida. Cancer Lett 2017
13
38

Proteasome inhibitors in cancer therapy.
Elisabet E Manasanch, Robert Z Orlowski. Nat Rev Clin Oncol 2017
448
7

Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.
Vesna Milacic, Sanjeev Banerjee, Kristin R Landis-Piwowar, Fazlul H Sarkar, Adhip P N Majumdar, Q Ping Dou. Cancer Res 2008
191
7

Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Daisuke Ito, Satomi Yogosawa, Rei Mimoto, Shinichi Hirooka, Takashi Horiuchi, Ken Eto, Katsuhiko Yanaga, Kiyotsugu Yoshida. Cancer Sci 2017
20
25

Reversible phosphorylation of Rpn1 regulates 26S proteasome assembly and function.
Xiaoyan Liu, Weidi Xiao, Yanan Zhang, Sandra E Wiley, Tao Zuo, Yingying Zheng, Natalie Chen, Lu Chen, Xiaorong Wang, Yawen Zheng,[...]. Proc Natl Acad Sci U S A 2020
22
22

Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner.
Mark J Ranek, Curtis K Kost, Chengjun Hu, Douglas S Martin, Xuejun Wang. J Mol Cell Cardiol 2014
20
20

mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy.
Jinghui Zhao, Bo Zhai, Steven P Gygi, Alfred Lewis Goldberg. Proc Natl Acad Sci U S A 2015
259
5

Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
Sougata Datta, Santosh K Misra, Manik Lal Saha, Nabajit Lahiri, Janis Louie, Dipanjan Pan, Peter J Stang. Proc Natl Acad Sci U S A 2018
49
8

Anticancer potential of curcumin: preclinical and clinical studies.
Bharat B Aggarwal, Anushree Kumar, Alok C Bharti. Anticancer Res 2003
5

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Bharat B Aggarwal, Shishir Shishodia, Yasunari Takada, Sanjeev Banerjee, Robert A Newman, Carlos E Bueso-Ramos, Janet E Price. Clin Cancer Res 2005
419
5

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.
Ricky A Sharma, Stephanie A Euden, Sharon L Platton, Darren N Cooke, Aisha Shafayat, Heather R Hewitt, Timothy H Marczylo, Bruno Morgan, David Hemingway, Simon M Plummer,[...]. Clin Cancer Res 2004
848
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.